A combretastatin-mediated decrease in neutrophil concentration in peripheral blood and the impact on the anti-tumor activity of this drug in two different murine tumor models.

by Anja Bille Bohn, Thomas Wittenborn, Anne Sofie Brems-Eskildsen, Tinne Laurberg, Lotte Bonde Bertelsen, Thomas Nielsen, Hans Stødkilde-Jørgensen, Bjarne Kuno Møller, Michael R Horsman
Published 2014-01-01